CompletedNot Applicable

Bare -Metal Stents and Drug -Eluting Stents in the Treatment of Patients With Vertebral Artery Ostium Stenosis

China168 participantsStarted 2014-01

Plain-language summary

The study hypothesizes that Drug -eluting stents are more effective in preventing restenosis than Bare-metal stents after Vertebral Artery Ostium stenting

Who can participate

Age range35 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: \- symptomatic posterior circulation ischemia including monor stroke (mRS ≤2) or TIA result from the stenosis in the vertebral artery ostium. 70% to 99% stenosis of vertebral artery ostium. Exclusion Criteria: * etiology of stenotic lesions not atherosclerosis patients had undergone previos interventions on the vertebral artery ostium ipsilateral severe stenotic lesions in subclavian artery involved as well as vertebral artery ostium

What they're measuring

Late loss in lumen diameter in follow-up ≥50%

Timeframe: 1 year

Death, non -fatal stroke 30 days after stent implantation associated with antiplatelet drugs

Timeframe: 30 days

Death, non -fatal stroke 12 months after stent implantation associated with antiplatelet drugs

Timeframe: 12 months

Trial details

NCT IDNCT02197559

SponsorXuanwu Hospital, Beijing

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2015-06

View on ClinicalTrials.gov More Ischemic Stroke trials